Table 1.

Numbers and genotypic frequencies of protein S–K196E mutation in the DVT and control groups


Genotypes

General population, no. (%)

DVT group, no. (%)
Additive model*   
   KK   3585 (98.2)   146 (90.7)  
   KE   66 (1.8)   13 (8.1)  
   EE   0 (0.0)   2 (1.2)  
   Total   3651 (100.0)   161 (100.0)  
Dominant model   
   KK   3585 (98.2)   146 (90.7)  
   KE + EE   66 (1.8)   15 (9.3)  
   Total
 
3651 (100.0)
 
161 (100.0)
 

Genotypes

General population, no. (%)

DVT group, no. (%)
Additive model*   
   KK   3585 (98.2)   146 (90.7)  
   KE   66 (1.8)   13 (8.1)  
   EE   0 (0.0)   2 (1.2)  
   Total   3651 (100.0)   161 (100.0)  
Dominant model   
   KK   3585 (98.2)   146 (90.7)  
   KE + EE   66 (1.8)   15 (9.3)  
   Total
 
3651 (100.0)
 
161 (100.0)
 

DNA genotyping was performed by the TaqMan allele discrimination method. We have adopted the numbering standards of the Nomenclature Working Group, wherein the A of the ATG of the initiator Met codon is denoted as nucleotide + 1, and the initial Met residue is denoted as amino acid + 1, resulting in the renaming of several mutant alleles.10  Comparisons between the DVT cases and the controls were analyzed using a χ2 test with the genotypes as independent variables (indicated by P and OR) or using multiple logistic analyses with the genotypes as independent variables and age and sex as covariates (indicated by P′ and OR′).

*

For comparison of general population to DVT group, P was not determined

For comparison of general population to DVT group, P < .001; OR = 5.58 (3.11-10.01); P′ < .001; OR′ = 4.72 (2.39-9.31)

Close Modal

or Create an Account

Close Modal
Close Modal